在息性癌症患者处方抗血栓药物的工具:回顾性评估
Angela Riveras1, Mirjam Crul1, Jozien van der Kloes1
1Department of Clinical Pharmacology and Pharmacy, Amsterdam University Medical Center, location Vrije Universiteit, Amsterdam, The Netherlands.
为息性癌症患者开发抗血栓剂方案是安全的,可能有助于识别不适当的药物使用. 这种工具有助于在寿命有限的患者中管理抗血栓治疗.
科学领域:
- 抚慰性护理是一种缓解性护理.
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 在性癌症患者中管理抗血栓治疗具有静脉血栓栓塞和严重出血的双重风险.
- 现有的指导方针对于在这个人群中处方抗血栓药物是有限的.
- 为指导药物管理,制定了一项抗血栓剂方案.
研究的目的:
- 评估新开发的抗血栓剂方案的安全性和实用性.
- 评估该计划对减轻癌症患者抗血栓剂的 (停止) 处方的影响.
- 确定该计划是否有助于识别可能不适当的抗血栓使用.
主要方法:
- 进行了一项回顾性,单中心临床队列观察性研究.
- 包括患有固体瘤和预期寿命不到3个月的患者,由息团队管理.
- 根据该方案治疗的患者和未接受治疗的患者之间的结果进行了比较.
主要成果:
- 47.6%的患者服用抗血栓剂; 72.1%的人遵守该方案.
- 11名患者经历了临床事件 (依附组7名,非依附组4名),不显著的差异 (p=0.726).
- 不遵守组中较高的事件率表明该计划安全.
结论:
- 抗血栓剂方案在缓性癌症患者的抗血栓剂治疗中似乎是安全的.
- 该计划可以帮助医疗保健专业人员识别和删除可能不合适的抗血栓剂.
- 需要进一步的前性研究来验证这个工具.
更多相关视频
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
09:02Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Cancer Survival Analysis
